1![The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability](https://www.pdfsearch.io/img/b138dde19bd930bbb232bb341ac9d13d.jpg) | Add to Reading ListSource URL: www.ibms.sinica.edu.twLanguage: English - Date: 2015-08-05 05:34:46
|
---|
2![NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript NIH Public Access Author Manuscript Clin Lymphoma Myeloma. Author manuscript; available in PMC 2009 November 30. NIH-PA Author Manuscript](https://www.pdfsearch.io/img/27ea5c63317ca64d044da162ed8ec750.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
3![MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSNOriginal Article Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Resid](https://www.pdfsearch.io/img/89c363f0360dab5a7f74d18e43737510.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
4![Acute_Promyelocytic_Leukemia.indd Acute_Promyelocytic_Leukemia.indd](https://www.pdfsearch.io/img/29a24a037589bb8857c1040ef780b65b.jpg) | Add to Reading ListSource URL: www.mayomedicallaboratories.comLanguage: English - Date: 2015-08-12 13:43:26
|
---|
5![Adult AML and Myelodysplastic Syndrome REMISSION INDUCTION INITIAL EVALUATION Adult AML and Myelodysplastic Syndrome REMISSION INDUCTION INITIAL EVALUATION](https://www.pdfsearch.io/img/22867bb7ef2db2cf08907a741861946a.jpg) | Add to Reading ListSource URL: www.rcctvm.orgLanguage: English - Date: 2007-09-18 09:59:54
|
---|
6![My Sister’s Keeper Science Background Talk
Outline Acute promyelocytic leukemia (APL) APL Treatment My Sister’s Keeper Science Background Talk
Outline Acute promyelocytic leukemia (APL) APL Treatment](https://www.pdfsearch.io/img/5e06d74134d3ba674a5a86b88909e3fc.jpg) | Add to Reading ListSource URL: www.scu.eduLanguage: English - Date: 2012-03-21 03:33:23
|
---|
7![EJEMPLO PLAN DE ASIGNATURA: EJEMPLO PLAN DE ASIGNATURA:](https://www.pdfsearch.io/img/87df3fd2e61847c89291c1e982769aac.jpg) | Add to Reading ListSource URL: www.cicancer.orgLanguage: English - Date: 2007-07-17 08:21:36
|
---|
8![Immunity in Cytogenetic Normal Acute Myeloid Leukaemia (iCN-AML) Stephen Ting Department of Haematology, Alfred Health & Australian Centre for Blood Diseases, ACBD, Immunity in Cytogenetic Normal Acute Myeloid Leukaemia (iCN-AML) Stephen Ting Department of Haematology, Alfred Health & Australian Centre for Blood Diseases, ACBD,](https://www.pdfsearch.io/img/9ff780c37e118f0b7bc4771f16bd78c8.jpg) | Add to Reading ListSource URL: southernmelbcancersymposium.orgLanguage: English - Date: 2014-10-21 20:28:42
|
---|
9![Researchers identify drug target for ATRA, the first precision cancer therapy Researchers identify drug target for ATRA, the first precision cancer therapy](https://www.pdfsearch.io/img/82d86e2fe9dc198ffe6580c0f756da88.jpg) | Add to Reading ListSource URL: medicalxpress.comLanguage: English - Date: 2015-05-04 12:15:46
|
---|
10![September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) - September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -](https://www.pdfsearch.io/img/d2bf7725d5dbafd2e3d4509e4627afda.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|